|
Price : 5 slide for 600 $
| CT1 Human, thyroid cancer | ||||||
| Age | Sex | Organ | Diagnosis | TNM | Stage | |
| 1 | 38 | F | thyroid | papillary carcinoma | T4N1aM0 | Ⅰ |
| 2 | 43 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅰ |
| 3 | 31 | F | thyroid | papillary carcinoma | T4N1aM0 | Ⅰ |
| 4 | 35 | F | thyroid | papillary carcinoma | T2NxM0 | Ⅰ |
| 5 | 41 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅰ |
| 6 | 57 | F | thyroid | papillary carcinoma | T4NxM0 | Ⅲ |
| 7 | 52 | F | thyroid | papillary carcinoma | T2N0M0 | Ⅱ |
| 8 | 45 | M | thyroid | papillary carcinoma | T4N0M0 | Ⅲ |
| 9 | 40 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅰ |
| 10 | 60 | F | thyroid | papillary carcinoma | T4N1M0 | Ⅲ |
| 11 | 48 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅲ |
| 12 | 29 | F | thyroid | papillary carcinoma | T2N1M0 | Ⅰ |
| 13 | 72 | M | thyroid | papillary carcinoma | T4N1bM0 | Ⅲ |
| 14 | 24 | M | thyroid | papillary carcinoma | T4N1M0 | Ⅰ |
| 15 | 37 | F | thyroid | follicular carcinoma | T2N0M0 | Ⅰ |
| 16 | 56 | F | thyroid | papillary carcinoma | T4N1bM0 | Ⅲ |
| 17 | 35 | M | thyroid | follicular carcinoma | T3N0M0 | Ⅰ |
| 18 | 55 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅲ |
| 19 | 35 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅰ |
| 20 | 54 | M | neck | papillary carcinoma | T4N1M0 | Ⅲ |
| 21 | 28 | F | thyroid | papillary carcinoma | T4N1aM0 | Ⅰ |
| 22 | 45 | F | thyroid | papillary carcinoma | T4N1M0 | Ⅲ |
| 23 | 46 | M | thyroid | papillary carcinoma | T4N0M0 | Ⅲ |
| 24 | 36 | F | thyroid | papillary carcinoma | T4N1M0 | Ⅰ |
| 25 | 67 | F | thyroid | papillary carcinoma | T4N1M0 | Ⅲ |
| 26 | 22 | F | thyroid | follicular carcinoma | T2N0M0 | Ⅰ |
| 27 | 45 | M | thyroid | papillary carcinoma | T4N1M0 | Ⅲ |
| 28 | 33 | F | thyroid | follicular carcinoma | T2N0M0 | Ⅰ |
| 29 | 36 | F | thyroid | papillary carcinoma | T2NxM0 | Ⅰ |
| 30 | 21 | F | thyroid | papillary carcinoma | T2N0M0 | Ⅰ |
| 31 | 22 | F | thyroid | papillary carcinoma | T4N1aM0 | Ⅰ |
| 32 | 18 | F | thyroid | papillary carcinoma | T4N1aM0 | Ⅰ |
| 33 | 17 | F | thyroid | papillary carcinoma | T2N0M0 | Ⅰ |
| 34 | 51 | F | thyroid | papillary carcinoma | T4N1M0 | Ⅲ |
| 35 | 50 | F | neck | papillary carcinoma | ||
| 36 | 57 | F | thyroid | follicular carcinoma | T2N0M0 | Ⅱ |
| 37 | 38 | F | thyroid | papillary carcinoma | T4N1M0 | Ⅰ |
| 38 | 20 | F | thyroid | papillary carcinoma | T4N1M0 | Ⅰ |
| 39 | 27 | F | thyroid | follicular carcinoma | T2N0M0 | Ⅰ |
| 40 | 65 | M | thyroid | follicular carcinoma | T3N0M0 | Ⅱ |
| 41 | 40 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅰ |
| 42 | 69 | F | thyroid | papillary carcinoma | T4N1aM0 | Ⅲ |
| 43 | 50 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅲ |
| 44 | 51 | M | thyroid | follicular carcinoma | T2N0M0 | Ⅱ |
| 45 | 53 | M | thyroid | poorly differentiated carcinoma | T4N0M0 | Ⅳ |
| 46 | 47 | M | thyroid | papillary carcinoma | T4N1M0 | Ⅲ |
| 47 | 63 | M | thyroid | papillary carcinoma | T2N0M0 | Ⅱ |
| 48 | 58 | M | thyroid | papillary carcinoma | T3N0M0 | Ⅱ |
| 49 | 75 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅲ |
| 50 | 15 | F | thyroid | papillary carcinoma | T4N0M0 | Ⅰ |
| 51 | 45 | M | thyroid | benign thyroid tissue (same patient of #8) | T4N0M0 | Ⅲ |
| 52 | 31 | F | thyroid | benign thyroid tissue | T4N0M0 | Ⅰ |
| 53 | 38 | F | thyroid | benign thyroid tissue | T4N0M0 | Ⅰ |
| 54 | 50 | F | thyroid | benign thyroid tissue (same patient of #43) | T4N0M0 | Ⅲ |
| 55 | 52 | M | thyroid | benign thyroid tissue | T2N1M0 | Ⅲ |
| 56 | 78 | F | thyroid | benign thyroid tissue | T2NxM1 | Ⅳ |
| 57 | 32 | F | thyroid | benign thyroid tissue | T4N1M0 | Ⅰ |
| 58 | 15 | F | thyroid | benign thyroid tissue (same patient of #50) | T4N0M0 | Ⅰ |
| 59 | 37 | F | thyroid | benign thyroid tissue | T2N0M0 | Ⅰ |
| 60 | carbon particle | |||||
| TNM and stage classification:thyroid carcinoma(AJCC 5th Edition) | ||||||
General Information of the Tissue Array Slide :
Applications
- Immunohistochemistry
- In situ hybridization, RNA or DNA
- Fluorescent in situ hybridization (FISH)
- In situ PCR, RNA or DNA
- TUNEL for apoptosis (Recommended procedures in www.tissue-array.com -> protocol)
Storage and stability
- Individual slide is paraffin-coated and put in an air-tight pack with inert gas.
- Tissue array slides are shipped in room temperature.
- If the slides are stored in 4 degree, they are good up to one year.
How processed
- Tissues were initially fixed with formalin except for some of the animal tissues.
- Then, dehydrated with gradient ethanol; typically 1 hour each progressive steps; 70%, 90%, 95%, 99%, 100% x 3 times.
- Cleared by xylene, three changes for 1 hour each.
- Infiltrated with 60°C paraffin, three changes for 1 hour each
- Microtoming in 4 µm thickness and put on silane coating slide from Muto Pure Chemicals (Japan)
Before use
- Dry slides for 1 hour in a oven at 60 degree.
- Dewax slides in xylene for 4 minutes x 5 times
- Hydrate slides in 100%, 95% and 75% ethanol for 3 minutes x 2 times each.
- Immerse slides in tap water for 5 minutes
Slide orientation
- In most of the slides with 59 or 60 cores, the orientation is as below unless indicated otherwise. #60 location is usually filled with carbon for orientation.
|
Shaded area |
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 |
| 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 |
| 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 |
| 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 |